Colorectal Cancer Diagnostics Market, Global Outlook and Forecast 2022-2028

July 2024 | 63 pages | ID: CEF2D13CE6A7EN
Market Monitor Global

Abstracts

Colorectal cancer diagnostics are a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan, ultrasound, MRI and molecular testing of the growing tumor.

This report contains market size and forecasts of Colorectal Cancer Diagnostics in Global, including the following market information:

Global Colorectal Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Colorectal Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

FOB Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Colorectal Cancer Diagnostics include Biocept, Cancer Genetics, Foundation Medicine, Sysmex Corporation, Danaher Corporation, Epigenomics, Illumina, Rosetta Genomics and Exact Science Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Colorectal Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Colorectal Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Colorectal Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)

• FOB Tests
• CTC Tests
• CEA Tests
• Others

Global Colorectal Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Colorectal Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics
• Others

Global Colorectal Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Colorectal Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Colorectal Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Colorectal Cancer Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Biocept
• Cancer Genetics
• Foundation Medicine
• Sysmex Corporation
• Danaher Corporation
• Epigenomics
• Illumina
• Rosetta Genomics
• Exact Science Corporation
• Pathway Genomics Corporation

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Colorectal Cancer Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Colorectal Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COLORECTAL CANCER DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Colorectal Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Colorectal Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Colorectal Cancer Diagnostics Players in Global Market
3.2 Top Global Colorectal Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Colorectal Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Colorectal Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Colorectal Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Colorectal Cancer Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Colorectal Cancer Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Colorectal Cancer Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Colorectal Cancer Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 FOB Tests
  4.1.3 CTC Tests
  4.1.4 CEA Tests
  4.1.5 Others
4.2 By Type - Global Colorectal Cancer Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Colorectal Cancer Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Colorectal Cancer Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Colorectal Cancer Diagnostics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Others
5.2 By Application - Global Colorectal Cancer Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Colorectal Cancer Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Colorectal Cancer Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Colorectal Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Colorectal Cancer Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Colorectal Cancer Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Colorectal Cancer Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Colorectal Cancer Diagnostics Revenue, 2017-2028
  6.3.2 US Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.3.3 Canada Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Colorectal Cancer Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Colorectal Cancer Diagnostics Revenue, 2017-2028
  6.4.2 Germany Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.4.3 France Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.4.5 Italy Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.4.6 Russia Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Colorectal Cancer Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Colorectal Cancer Diagnostics Revenue, 2017-2028
  6.5.2 China Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.5.3 Japan Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.5.6 India Colorectal Cancer Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Colorectal Cancer Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Colorectal Cancer Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Colorectal Cancer Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.7.3 Israel Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Colorectal Cancer Diagnostics Market Size, 2017-2028
  6.7.5 UAE Colorectal Cancer Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Biocept
  7.1.1 Biocept Corporate Summary
  7.1.2 Biocept Business Overview
  7.1.3 Biocept Colorectal Cancer Diagnostics Major Product Offerings
  7.1.4 Biocept Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 Biocept Key News
7.2 Cancer Genetics
  7.2.1 Cancer Genetics Corporate Summary
  7.2.2 Cancer Genetics Business Overview
  7.2.3 Cancer Genetics Colorectal Cancer Diagnostics Major Product Offerings
  7.2.4 Cancer Genetics Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Cancer Genetics Key News
7.3 Foundation Medicine
  7.3.1 Foundation Medicine Corporate Summary
  7.3.2 Foundation Medicine Business Overview
  7.3.3 Foundation Medicine Colorectal Cancer Diagnostics Major Product Offerings
  7.3.4 Foundation Medicine Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 Foundation Medicine Key News
7.4 Sysmex Corporation
  7.4.1 Sysmex Corporation Corporate Summary
  7.4.2 Sysmex Corporation Business Overview
  7.4.3 Sysmex Corporation Colorectal Cancer Diagnostics Major Product Offerings
  7.4.4 Sysmex Corporation Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Sysmex Corporation Key News
7.5 Danaher Corporation
  7.5.1 Danaher Corporation Corporate Summary
  7.5.2 Danaher Corporation Business Overview
  7.5.3 Danaher Corporation Colorectal Cancer Diagnostics Major Product Offerings
  7.5.4 Danaher Corporation Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Danaher Corporation Key News
7.6 Epigenomics
  7.6.1 Epigenomics Corporate Summary
  7.6.2 Epigenomics Business Overview
  7.6.3 Epigenomics Colorectal Cancer Diagnostics Major Product Offerings
  7.6.4 Epigenomics Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 Epigenomics Key News
7.7 Illumina
  7.7.1 Illumina Corporate Summary
  7.7.2 Illumina Business Overview
  7.7.3 Illumina Colorectal Cancer Diagnostics Major Product Offerings
  7.7.4 Illumina Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 Illumina Key News
7.8 Rosetta Genomics
  7.8.1 Rosetta Genomics Corporate Summary
  7.8.2 Rosetta Genomics Business Overview
  7.8.3 Rosetta Genomics Colorectal Cancer Diagnostics Major Product Offerings
  7.8.4 Rosetta Genomics Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 Rosetta Genomics Key News
7.9 Exact Science Corporation
  7.9.1 Exact Science Corporation Corporate Summary
  7.9.2 Exact Science Corporation Business Overview
  7.9.3 Exact Science Corporation Colorectal Cancer Diagnostics Major Product Offerings
  7.9.4 Exact Science Corporation Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.9.5 Exact Science Corporation Key News
7.10 Pathway Genomics Corporation
  7.10.1 Pathway Genomics Corporation Corporate Summary
  7.10.2 Pathway Genomics Corporation Business Overview
  7.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics Major Product Offerings
  7.10.4 Pathway Genomics Corporation Colorectal Cancer Diagnostics Revenue in Global Market (2017-2022)
  7.10.5 Pathway Genomics Corporation Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Colorectal Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Colorectal Cancer Diagnostics Market Drivers in Global Market
Table 3. Colorectal Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Colorectal Cancer Diagnostics in Global Market
Table 5. Top Colorectal Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Colorectal Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Colorectal Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Colorectal Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Colorectal Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Colorectal Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Colorectal Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Colorectal Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Colorectal Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Colorectal Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Colorectal Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Colorectal Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Biocept Corporate Summary
Table 31. Biocept Colorectal Cancer Diagnostics Product Offerings
Table 32. Biocept Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Cancer Genetics Corporate Summary
Table 34. Cancer Genetics Colorectal Cancer Diagnostics Product Offerings
Table 35. Cancer Genetics Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Foundation Medicine Corporate Summary
Table 37. Foundation Medicine Colorectal Cancer Diagnostics Product Offerings
Table 38. Foundation Medicine Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Sysmex Corporation Corporate Summary
Table 40. Sysmex Corporation Colorectal Cancer Diagnostics Product Offerings
Table 41. Sysmex Corporation Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Danaher Corporation Corporate Summary
Table 43. Danaher Corporation Colorectal Cancer Diagnostics Product Offerings
Table 44. Danaher Corporation Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Epigenomics Corporate Summary
Table 46. Epigenomics Colorectal Cancer Diagnostics Product Offerings
Table 47. Epigenomics Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Illumina Corporate Summary
Table 49. Illumina Colorectal Cancer Diagnostics Product Offerings
Table 50. Illumina Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Rosetta Genomics Corporate Summary
Table 52. Rosetta Genomics Colorectal Cancer Diagnostics Product Offerings
Table 53. Rosetta Genomics Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Exact Science Corporation Corporate Summary
Table 55. Exact Science Corporation Colorectal Cancer Diagnostics Product Offerings
Table 56. Exact Science Corporation Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Pathway Genomics Corporation Corporate Summary
Table 58. Pathway Genomics Corporation Colorectal Cancer Diagnostics Product Offerings
Table 59. Pathway Genomics Corporation Colorectal Cancer Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Colorectal Cancer Diagnostics Segment by Type in 2021
Figure 2. Colorectal Cancer Diagnostics Segment by Application in 2021
Figure 3. Global Colorectal Cancer Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Colorectal Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Colorectal Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Colorectal Cancer Diagnostics Revenue in 2021
Figure 8. By Type - Global Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Colorectal Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Colorectal Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Biocept Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cancer Genetics Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Foundation Medicine Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sysmex Corporation Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Danaher Corporation Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Epigenomics Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Illumina Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Rosetta Genomics Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Exact Science Corporation Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pathway Genomics Corporation Colorectal Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)